Trinity Biotech plc (TRIB) Stock Price

TRIBStock

$9.71−78.07%52W

Market Cap$7.90M

P/E—

PEG Ratio0.30

Div yield—

Beta1.00

TRIB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-65.94%

Price vs S&P 500 (4W)-20.08%

PEG Ratio0.30

VGM Score31.26

Book Value / Share (Quarterly)$0.20

P/TBV (Annual)281.74x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-11.20%

Cash Flow / Share (Quarterly)$-0.03

Price vs S&P 500 (YTD)-68.37%

Gross Margin (TTM)32.88%

Net Profit Margin (TTM)-72.78%

EPS (TTM)$-0.10

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-0.10

Revenue Growth (5Y)-15.56%

EPS (Annual)$-0.10

ROI (Annual)-27.05%

Gross Margin (Annual)38.57%

Net Profit Margin (5Y Avg)-48.75%

Cash / Share (Quarterly)$0.01

Revenue Growth QoQ (YoY)-30.18%

ROA (Last FY)-35.54%

Revenue Growth TTM (YoY)-16.57%

EBITD / Share (TTM)$-0.04

ROE (5Y Avg)-161.55%

Operating Margin (TTM)-30.74%

Cash Flow / Share (Annual)$-0.03

P/B Ratio1.00x

P/B Ratio (Quarterly)3.37x

Net Income / Employee (Annual)$-93,200

EV / Revenue (TTM)2.72x

Net Interest Coverage (TTM)-0.74x

ROA (TTM)-36.62%

EV / EBITDA (TTM)1835.58x

EPS Incl Extra (Annual)$-0.10

Current Ratio (Annual)0.25x

Quick Ratio (Quarterly)0.12x

3-Month Avg Trading Volume0.04M

52-Week Price Return-78.07%

Revenue / Employee (TTM)$128,100

Tangible BV / Share (Quarterly)$0.02

P/S Ratio (Annual)0.15x

Asset Turnover (Annual)0.42x

52-Week High$52.50

Operating Margin (5Y Avg)-28.83%

EPS Excl Extra (Annual)$-0.10

CapEx CAGR (5Y)-9.41%

Tangible BV CAGR (5Y)-67.56%

26-Week Price Return-54.69%

Quick Ratio (Annual)0.11x

13-Week Price Return-44.91%

Total Debt / Equity (Annual)21.68x

Current Ratio (Quarterly)0.25x

Enterprise Value$139.50M

Revenue / Share Growth (5Y)-37.33%

Asset Turnover (TTM)0.50x

Book Value / Share Growth (5Y)-52.97%

Revenue / Employee (Annual)$109,200

Inventory Turnover (Annual)1.41x

Pretax Margin (Annual)-84.91%

Cash / Share (Annual)$0.01

3-Month Return Std Dev142.34%

Gross Margin (5Y Avg)35.29%

Net Income / Employee (TTM)$-93,200

ROE (Last FY)-613.49%

Net Interest Coverage (Annual)-0.74x

EPS Basic Excl Extra (Annual)$-0.10

P/FCF (TTM)10.83x

Receivables Turnover (TTM)3.73x

Total Debt / Equity (Quarterly)8.73x

EPS Incl Extra (TTM)$-0.10

Receivables Turnover (Annual)3.72x

ROI (TTM)-24.46%

P/S Ratio (TTM)0.13x

Pretax Margin (5Y Avg)-54.44%

Revenue / Share (Annual)$0.12

Tangible BV / Share (Annual)$0.02

Price vs S&P 500 (52W)-96.38%

Year-to-Date Return-56.41%

5-Day Price Return-16.89%

EPS Normalized (Annual)$-0.10

ROA (5Y Avg)-30.10%

Net Profit Margin (Annual)-85.36%

Month-to-Date Return-10.95%

Cash Flow / Share (TTM)$-1.26

EBITD / Share (Annual)$-0.04

Operating Margin (Annual)-36.06%

LT Debt / Equity (Annual)17.40x

ROI (5Y Avg)-22.34%

LT Debt / Equity (Quarterly)8.70x

EPS Basic Excl Extra (TTM)$-0.10

P/TBV (Quarterly)281.74x

P/B Ratio (Annual)5.27x

Inventory Turnover (TTM)1.41x

Pretax Margin (TTM)-72.39%

Book Value / Share (Annual)$0.25

Price vs S&P 500 (13W)-47.70%

Beta1.00x

P/FCF (Annual)1.46x

Revenue / Share (TTM)$0.14

ROE (TTM)-166.14%

52-Week Low$7.94

vGradeB

gGradeD

mGradeF

vgmGradeD

TRIB Earnings Surprise History

Q2 24-14.00est. -19.50

Q3 24-12.77est. -16.20

Q4 24-26.35est. -9.00

Q1 25-14.40est. —

TRIB Analyst Recommendations

Oct 2022

Nov 2022

Dec 2022

Jan 2023

4.29

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
TRIBTrinity Biotech plc	B	D	F	$9.71
IDXXIdexx Laboratories Inc	D	B	C	$550.01
LNTHLantheus Holdings, Inc	C	B	B	$100.87
CLDXCelldex Therapeutics, Inc	F	F	B	$41.22
NEOGNeogen Corp	C	C	B	$11.64
NTLAIntellia Therapeutics, Inc	D	D	C	$13.51
QDELQuidelOrtho Corporation Common Stock	C	C	C	$15.05
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.17
TKNOAlpha Teknova, Inc. Common Stock	D	C	A	$7.46
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.83
MYGNMyriad Genetics Inc	B	C	D	$3.19
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.44
ICCCImmucell Corp	C	B	B	$9.84
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.44
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	B	$1.91
BMRABIOMERICA INC	B	D	D	$1.77
VNRXVolitionRx Limited	B	A	F	$0.38
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	D	$2.91
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	C	$0.01

About Trinity Biotech plc

Trinity Biotech develops and manufactures clinical diagnostic products for laboratory and point-of-care testing, focusing on detection of autoimmune, infectious, and sexually transmitted diseases, as well as diabetes and organ-specific disorders. The company also supplies raw materials to the global life sciences and research industries. The Americas segment accounts for the majority of revenue.